<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/High_Cholesterol.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:30:42 GMT -->
<head>
<meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
<meta name="Language" content="es">
<meta name="ContentID" content="1028005">
<meta name="Category" content="Concern">
<meta name="Article" content="High_Cholesterol">
<title>Colesterol Elevado-Referencias</title>
<link type="text/css" rel="stylesheet" href="../Styles/hnqrHtml.css">
<base target="_self">
</head>
<body>
<div id="Article-Title" class="Article-Title"><a name="Article-Title"></a> 

<p class="Article-Title">Colesterol elevado</p>
</div>

<div id="Reference-List" class="Reference-List">
<p class="Reference-Autofill"><a href="High_Cholesterol.htm">Volver al
art&#237;culo.</a></p>

<h3>Referencias para el art&#237;culo</h3>

<ol class="Reference-List">
<li class="Ref">Kromhout D, Menotti A, Bloemberg B, et al. Dietary saturated and trans fatty
acids and cholesterol and 25-year mortality from coronary heart disease: the Seven Countries
Study. <em>Prev Med</em> 1995;24:308&#8211;15.</li>

<li class="Ref">Tell GS, Evans GW, Folsom AR, et al. Dietary fat intake and carotid artery
wall thickness: the Atherosclerosis Risk in Communities (ARIC) study. <em>Am J Epidemiol</em>
1994;139:979&#8211;89.</li>

<li class="Ref">Ornish D, Brown SE, Scherwitz LW, et al. Can lifestyle changes reverse
coronary heart disease? The Lifestyle Heart Trial. <em>Lancet</em> 1990;336:129&#8211;33.</li>

<li class="Ref">Denke MA, Grundy SM. Comparison of effects of lauric acid and palmitic acid on
plasma lipids and lipoproteins. <em>Am J Clin Nutr</em> 1992;56:895&#8211;8.</li>

<li class="Ref">Zock PL, de Vries JHM, Katan MB. Impact of myristic acid versus palmitic acid
on serum lipid and lipoprotein levels in healthy women and men. <em>Arterioscler Thromb</em>
1994;14:567&#8211;75.</li>

<li class="Ref">Kumar PD. The role of coconut and coconut oil in coronary heart disease in
Kerala, south India. <em>Trop Doct</em> 1997;27:215&#8211;7.</li>

<li class="Ref">Denke MA, Grundy SM. Comparison of effects lof auric acid and palmitic acid on
plasma lipids and lipoproteins. <em>Am J Clin Nutr</em> 1992;56:895&#8211;8.</li>

<li class="Ref">Mendis S, Kumarasunderam R. The effect of daily consumption of coconut fat and
soya-bean fat on plasma lipids and lipoproteins of young normolipidaemic men. <em>Br J
Nutr</em> 1990;63:547&#8211;52.</li>

<li class="Ref">Dreon DM, Fernstrom HA, Williams PT, Krauss RM. A very-low-fat diet is not
associated with improved lipoprotein profiles in men with a predominance of large, low-density
lipoproteins. <em>Am J Clin Nutr</em> 1999;69:411&#8211;8.</li>

<li class="Ref">Hepner G, Fried R, St Jeor S, et al. Hypocholesterolemic effect of yogurt and
milk. <em>Am J Clin Nutr</em> 1979;19&#8211;24.</li>

<li class="Ref">Agerholm-Larsen L, Raben A, Haulrik N, et al. Effect of 8 week intake of
probiotic milk products on risk factors for cardiovascular diseases. <em>Eur J Clin Nutr</em>
2000;54:288&#8211;97.</li>

<li class="Ref">Bertolami MC, Faludi AA, Batlouni M. Evaluation of the effects of a new
fermented milk product (Gaio) on primary hypercholesterolemia. <em>Eur J Clin Nutr</em>
1999;53:97&#8211;101.</li>

<li class="Ref">Anderson JW, Gilliland SE. Effect of fermented milk (yogurt) containing
Lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemic humans. <em>J Am
Coll Nutr</em> 1999;18:43&#8211;50.</li>

<li class="Ref">Schaafsma G, Meuling WJ, van Dokkum W, Bouley C. Effects of a milk product,
fermented by Lactobacillus acidophilus and with fructo-oligosaccharides added, on blood lipids
in male volunteers. <em>Eur J Clin Nutr</em> 1998;52:436&#8211;40.</li>

<li class="Ref">Agerbaek M, Gerdes LU, Richelsen B. Hypocholesterolaemic effect of a new
fermented milk product in healthy middle-aged men. <em>Eur J Clin Nutr</em>
1995;49:346&#8211;52.</li>

<li class="Ref">Richelsen B, Kristensen K, Pedersen SB. Long-term (6 months) effect of a new
fermented milk product on the level of plasma lipoproteins&#8212;a placebo-controlled and
double blind study. <em>Eur J Clin Nutr</em> 1996;50:811&#8211;5.</li>

<li class="Ref">De Roos NM, Schouten G, Katan MB. Yoghurt enriched with <em>Lactobacillus
acidophilus</em> does not lower blood lipids in healthy men and women with normal to
borderline high serum cholesterol levels. <em>Eur J Clin Nutr</em> 1999;53:277&#8211;80.</li>

<li class="Ref">Thompson LU, Jenkins DJ, Amer MA, et al. The effect of fermented and
unfermented milks on serum cholesterol. <em>Am J Clin Nutr</em> 1982;36:1106&#8211;11.</li>

<li class="Ref">Rossouw JE, Burger EM, Van der Vyver P, Ferreira JJ. The effect of skim milk,
yoghurt, and full cream milk on human serum lipids. <em>Am J Clin Nutr</em>
1981;34:351&#8211;6.</li>

<li class="Ref">Santos MJ, Lopez-Jurado M, Llopis J, et al. Influence of dietary
supplementation with fish on plasma total cholesterol and lipoprotein cholesterol fractions in
patients with coronary heart disease. <em>J Nutr Med</em> 1992;3:107&#8211;15.</li>

<li class="Ref">Kromhout D, Bosschieter EB, Coulander CD. The inverse relation between fish
consumption and 20-year mortality from coronary heart disease. <em>N Engl J Med</em>
1985;312:1205&#8211;9.</li>

<li class="Ref">Ascherio A, Rimm EG, Stampfer MJ, et al. Dietary intake of marine n-3 fatty
acids, fish intake, and the risk of coronary disease among men. <em>N Engl J Med</em>
1995;332:977&#8211;82.</li>

<li class="Ref">Albert CM, Manson JE, O&#8217;Donnell C, et al. Fish consumption and the risk
of sudden death in the Physicians&#8217; Health Study. <em>Circulation</em> 1996;94(Suppl
1):I&#8211;578 [abstract #3382].</li>

<li class="Ref">Thorogood M, Carter R, Benfield L, et al. Plasma lipids and lipoprotein
cholesterol concentrations in people with different diets in Britain. <em>Br Med J</em> (Clin
Res Ed) 1987;295:351&#8211;3.</li>

<li class="Ref">Burr ML, Sweetnam PM. Vegetarianism, dietary fiber and mortality. <em>Am J
Clin Nutr</em> 1982;36:873&#8211;7.</li>

<li class="Ref">Resnicow K, Barone J, Engle A, et al. Diet and serum lipids in vegan
vegetarians: a model for risk reduction. <em>J Am Dietet Assoc</em> 1991;91:447&#8211;53.</li>

<li class="Ref">Ornish D, Brown SE, Scherwitz LW, et al. Can lifestyle changes reverse
coronary heart disease? The Lifestyle Heart Trial. <em>Lancet</em> 1990;336:129&#8211;33.</li>

<li class="Ref">Ornish D, Scherwitz LW, Billings JH, et al. Intensive lifestyle changes for
reversal of coronary heart disease. <em>JAMA</em> 1998;280:2001&#8211;7.</li>

<li class="Ref">Connor SL, Connor WE. The importance of dietary cholesterol in coronary heart
disease. <em>Prev Med</em> 1983;12:115&#8211;23 [review].</li>

<li class="Ref">Edington JD, Geekie M, Carter R, et al. Serum lipid response to dietary
cholesterol in subjects fed a low-fat, high-fiber diet. <em>Am J Clin Nutr</em>
1989;50:58&#8211;62.</li>

<li class="Ref">Raloff J. Oxidized lipids: a key to heart disease? <em>Sci News</em>
1985;127:278.</li>

<li class="Ref">Levy Y, Maor I, Presser D, Aviram M. Consumption of eggs with meals increases
the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. <em>Ann
Nutr Metabol</em> 1996;40:243&#8211;51.</li>

<li class="Ref">Shekelle RB, Stamler J. Dietary cholesterol and ischaemic heart disease. <em>
Lancet</em> 1989;i:1177&#8211;9.</li>

<li class="Ref">Hu FB, Stampfer MJ, Rimm EB, et al. A prospective study of egg consumption and
risk of cardiovascular disease in men and women. <em>JAMA</em> 1999;281:1387&#8211;94.</li>

<li class="Ref">Anderson JW, Chen WJL. Legumes and their soluble fiber: effect on
cholesterol-rich lipoproteins. In: Furda I, ed. <em>Unconventional Sources of Dietary
Fiber</em>. Washington, DC: American Chemical Society, 1983.</li>

<li class="Ref">Ripsin CM, Keenan JM, Jacobs DR, et al. Oat products and lipid
lowering&#8212;a meta-analysis. <em>JAMA</em> 1992;267:3317&#8211;25.</li>

<li class="Ref">Anderson JW, Allgood LD, Lawrence A, et al. Cholesterol-lowering effects of
psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia:
meta-analysis of 8 controlled trials. <em>Am J Clin Nutr</em> 2000;71:472&#8211;9.</li>

<li class="Ref">Miettinen TA, Tarpila S. Effect of pectin on serum cholesterol, fecal bile
acids and biliary lipids in normolipidemic and hyperlipidemic individuals. <em>Clin Chim
Acta</em> 1977;79:471&#8211;7.</li>

<li class="Ref">Glore SR, Van Treeck D, Knehans AW, Guild M. Soluble fiber and serum lipids: a
literature review. <em>J Am Dietet Assoc</em> 1994;94:425&#8211;36.</li>

<li class="Ref">Romero AL, Romero JE, Galaviz S, Fernandez ML. Cookies enriched with psyllium
or oat bran lower plasma LDL cholesterol in normal and hypercholesterolemic men from Northern
Mexico. <em>J Am Coll Nutr</em> 1998;17:601&#8211;8.</li>

<li class="Ref">Rimm EB, Ascherio A, Giovannucci E, et al. Vegetable, fruit, and cereal fiber
intake and risk of coronary heart disease among men. <em>JAMA</em> 1996;275:447&#8211;51.</li>

<li class="Ref">Knopp RH, Superko HR, Davidson M, et al. Long-term blood cholesterol-lowering
effects of a dietary fiber supplement. <em>Am J Prev Med</em> 1999;17:18&#8211;23.</li>

<li class="Ref">Lovegrove JA, Clohessy A, Milon H, Williams CM. Modest doses of beta-glucan do
not reduce concentrations of potentially atherogenic lipoproteins. <em>Am J Clin Nutr</em>
2000;72:49&#8211;55.</li>

<li class="Ref">Uusitupa MI, Ruuskanen E, Makinen E, et al. A controlled study on the effect
of beta-glucan-rich oat bran on serum lipids in hypercholesterolemic subjects: relation to
apolipoprotein E phenotype. <em>J Am Coll Nutr</em> 1992;11:651&#8211;9.</li>

<li class="Ref">Braaten JT, Wood PJ, Scott FW, et al. Oat beta-glucan reduces blood
cholesterol concentration in hypercholesterolemic subjects. <em>Eur J Clin Nutr</em>
1994;48:465&#8211;74.</li>

<li class="Ref">Davidson MH, Dugan LD, Burns JH, et al. The hypocholesterolemic effects of
beta-glucan in oatmeal and oat bran. A dose-controlled study. <em>JAMA</em>
1991;265:1833&#8211;9.</li>

<li class="Ref">Onning G, Wallmark A, Persson M, et al. Consumption of oat milk for 5 weeks
lowers serum cholesterol and LDL cholesterol in free-living men with moderate
hypercholesterolemia. <em>Ann Nutr Metab</em> 1999;43:301&#8211;9.</li>

<li class="Ref">Beer MU, Arrigoni E, Amado R. Effects of oat gum on blood cholesterol levels
in healthy young men. <em>Eur J Clin Nutr</em> 1995;49:517&#8211;22.</li>

<li class="Ref">Bierenbaum ML, Reichstein R, Watkins TR. Reducing atherogenic risk in
hyperlipemic humans with flaxseed supplementation: a preliminary report. <em>J Am Coll
Nutr</em> 1993;12:501&#8211;4.</li>

<li class="Ref">Cunnane SC, Ganguli S, Menard C, et al. High alpha-linolenic acid flaxseed
<em>(Linum usitatissimum)</em>: some nutritional properties in humans. <em>Br J Nutr</em>
1993;69:443&#8211;53.</li>

<li class="Ref">Arjmandi BH, Khan DA, Juma S, et al. Whole flaxseed consumption lowers serum
LDL-cholesterol and lipoprotein(a) concentrations in postmenopausal women. <em>Nutr Res</em>
1998;18:1203&#8211;14.</li>

<li class="Ref">Jenkins DJA, Kendall CWC, Vidgen E, et al. Health aspects of partially
defatted flaxseed, including effects on serum lipids, oxidative measures, and ex vivo androgen
and progestin activity: a controlled crossover trial. <em>Am J Clin Nutr</em>
1999;69:395&#8211;402.</li>

<li class="Ref">Kelley DS, Nelson GJ, Love JE, et al. Dietary alpha-linolenic acid alters
tissue fatty acid composition, but not blood lipids, lipoproteins or coagulation status in
humans. <em>Lipids</em> 1993;28:533&#8211;7.</li>

<li class="Ref">Chan JK, Bruce VM, McDonald BE. Dietary a-linolenic acid is as effective as
oleic acid and linoleic acid in lowering blood cholesterol in normolipidemic men. <em>Am J
Clin Nutr</em> 1991;53:1230&#8211;4.</li>

<li class="Ref">Pang D, Allman-Farinelli MA, Wong T, et al. Replacement of linoleic acid with
alpha-linolenic acid does not alter blood lipids in normolipidaemic men. <em>Br J Nutr</em>
1998;80:163&#8211;7.</li>

<li class="Ref">Mantzioris E, James MJ, Bibson RA, Cleland LG. Dietary substitution with an
alpha-linolenic acid-rich vegetable oil increases eicosapentaenoic acid concentrations in
tissues. <em>Am J Clin Nutr</em> 1994;59:1304&#8211;9.</li>

<li class="Ref">Layne KS, Goh YK, Jumpsen JA, et al. Normal subjects consuming physiological
levels of 18:3(n-3) and 20:5(n-3) from flaxseed or fish oils have characteristic differences
in plasma lipid and lipoprotein fatty acid levels. <em>J Nutr</em>
1996;126:2130&#8211;40.</li>

<li class="Ref">Nestel PJ, Pomeroy SE, Sasahara T, et al. Arterial compliance in obese
subjects is improved with dietary plant n-3 fatty acid from flaxseed oil despite increased LDL
oxidizability. <em>Arterioscler Thromb Vasc Biol</em> 1997;17:1163&#8211;70.</li>

<li class="Ref">De Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean alpha-linolenic-rich
diet in secondary prevention of coronary heart disease. <em>Lancet</em>
1994;343:1454&#8211;9.</li>

<li class="Ref">De Lorgeril M, Salen P, Martin J-L, et al. Mediterranean diet, traditional
risk factors, and the rate of cardiovascular complications after myocardial infarction. Final
report of the Lyon Diety Heart Study. <em>Circulation</em> 1999;99:779&#8211;85.</li>

<li class="Ref">Rice RD. Mediterranean diet. <em>Lancet</em> 1994;344:893&#8211;4
[letter].</li>

<li class="Ref">Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy
protein intake on serum lipids. <em>N Engl J Med</em> 1995;3333:276&#8211;82.</li>

<li class="Ref">Sirtori CR, Pazzucconi F, Colombo L, et al. Double-blind study of the addition
of high-protein soya milk v. cows&#8217; milk to the diet of patients with severe
hypercholesterolaemia and resistance to or intolerance of statins. <em>Br J Nutr</em>
1999;82:91&#8211;6.</li>

<li class="Ref">Teixeira SR, Potter SM, Weigel R, et al. Effects of feeding 4 levels of soy
protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic
men. <em>Am J Clin Nutr</em> 2000;71:1077&#8211;84.</li>

<li class="Ref">Baum JA, Teng H, Erdman JW Jr, et al. Long-term intake of soy protein improves
blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger
RNA in hypercholesterolemic, postmenopausal women. <em>Am J Clin Nutr</em>
1998;68:545&#8211;51.</li>

<li class="Ref">Crouse JR 3rd, Morgan T, Terry JG, et al. A randomized trial comparing the
effect of casein with that of soy protein containing varying amounts of isoflavones on plasma
concentrations of lipids and lipoproteins. <em>Arch Intern Med</em>
1999;159:2070&#8211;6.</li>

<li class="Ref">Teixeira SR, Potter SM, Weigel R, et al. Effects of feeding 4 levels of soy
protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic
men. <em>Am J Clin Nutr</em> 2000;71:1077&#8211;84.</li>

<li class="Ref">Potter SM, Baum JA, Teng H, et al. Soy protein and isoflavones: their effects
on blood lipids and bone density in postmenopausal women. <em>Am J Clin Nutr</em>
1998;68:1375&#8211;79S.</li>

<li class="Ref">Crouse JR 3rd, Morgan T, Terry JG, et al. A randomized trial comparing the
effect of casein with that of soy protein containing varying amounts of isoflavones on plasma
concentrations of lipids and lipoproteins. <em>Arch Intern Med</em>
1999;159:2070&#8211;6.</li>

<li class="Ref">Greaves KA, Parks JS, Williams JK, Wagner JD. Intact dietary soy protein, but
not adding an isoflavone-rich soy extract to casein, improves plasma lipids in ovariectomized
cynomolgus monkeys. <em>J Nutr</em> 1999;129:1585&#8211;92.</li>

<li class="Ref">Greaves KA, Wilson MD, Rudel LL, et al. Consumption of soy protein reduces
cholesterol absorption compared to casein protein alone or supplemented with an isoflavone
extract or conjugated equine estrogen in ovariectomized cynomolgus monkeys. <em>J Nutr</em>
2000;130:820&#8211;6.</li>

<li class="Ref">Yudkin J, Kang SS, Bruckdorfer KR. Effects of high dietary sugar. <em>Br Med
J</em> 1980;281:1396.</li>

<li class="Ref">Reiser S. Effect of dietary sugars on metabolic risk factors associated with
heart disease. <em>Nutr Health</em> 1985;3:203&#8211;16.</li>

<li class="Ref">Liu K, Stamler J, Trevisan M, Moss D. Dietary lipids, sugar, fiber, and
mortality from coronary heart disease. Bivariate analysis of international data. <em>
Arteriosclerosis</em> 1982;2:221&#8211;7.</li>

<li class="Ref">Urgert R, Schulz AG, Katan MB. Effects of cafestol and kahweol from coffee
grounds on serum lipids and serum liver enzymes in humans. <em>Am J Clin Nutr</em>
1995;61:149&#8211;54.</li>

<li class="Ref">Superko HR, Bortz WM, Albers JJ, Wood PJ. Lipoprotein and apolipoprotein
changes during a controlled trial of caffeinated and decaffeinated coffee drinking in men.
<em>Circulation</em> 1989;80:II&#8211;86.</li>

<li class="Ref">Nyg&#228;rd O, Refsum H, Velanb PM, et al. Coffee consumption and plasma total
homocysteine: the Hordaland Homocysteine Study. <em>Am J Clin Nutr</em>
1997;65:136&#8211;43.</li>

<li class="Ref">Gross G, Jaccaud E, Huggett AC. Analysis of the content of the diterpenes
cafestol and kahweol in coffee brews. <em>Food Chem Toxicol</em> 1997;35:547&#8211;54.</li>

<li class="Ref">D&#8217;Amicis A, Scaccini C, Tomassi G, et al. Italian style brewed coffee:
effect on serum cholesterol in young men. <em>Int J Epidemiol</em> 1996;25:513&#8211;20.</li>

<li class="Ref">D&#8217;Avanzo B, Santoro L, Nobill A, La Vecchia C. Coffee consumption and
serum cholesterol. GISSI-EFRIM Study Group. <em>Prev Med</em> 1993;22:219&#8211;24.</li>

<li class="Ref">[No authors listed.] Regular or decaf? Coffee consumption and serum
lipoproteins. <em>Nutr Rev</em> 1992;50:175&#8211;8 [review].</li>

<li class="Ref">Dai WS, Laporte RE, Hom DL, et al. Alcohol consumption and high density
lipoprotein cholesterol concentration among alcoholics. <em>Am J Epidemiol</em>
1985;122:620&#8211;7.</li>

<li class="Ref">Marques-Vidal P, Ducimetiere P, Evans A, et al. Alcohol consumption and
myocardial infarction: a case-control study in France and northern Ireland. <em>Am J
Epidemiol</em> 1996;143:1089&#8211;93.</li>

<li class="Ref">Rimm EB, Klatsky A, Grobbee D, Stampfer MJ. Review of moderate alcohol
consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or
spirits? <em>BMJ</em> 1996;312:731&#8211;6 [review].</li>

<li class="Ref">Hendriks HF, Veenstra J, Velthuis-te Wierik EJ, et al. Effect of moderate dose
of alcohol with evening meal on fibrinolytic factors. <em>BMJ</em> 1994;304:1003&#8211;6.</li>

<li class="Ref">Doll R, Peto AR, Hall E, et al. Mortality in relation to consumption of
alcohol: 13 years&#8217; observations on male British doctors. <em>BMJ</em>
1994;309:911&#8211;8.</li>

<li class="Ref">Hein HO, Suadicani P, Gyntelberg F. Alcohol consumption, serum low density
lipoprotein cholesterol concentration, and risk of ischaemic heart disease: six year follow up
in the Copenhagen male study. <em>BMJ</em> 1996;736&#8211;41.</li>

<li class="Ref">Baggio G, Pagnan A, Muraca M, et al. Olive-oil-enriched diet: effect on serum
lipoprotein levels and biliary cholesterol saturation. <em>Am J Clin Nutr</em>
1988;47:960&#8211;4.</li>

<li class="Ref">Kris-Etherton PM, Pearson TA, Wan Y, et al. High-monounsaturated fatty acid
diets lower both plasma cholesterol and triacylglycerol concentrations. <em>Am J Clin
Nutr</em> 1999;70:1009&#8211;15.</li>

<li class="Ref">Grundy SM. Monounsaturated fatty acids and cholesterol metabolism:
implications for dietary recommendations. <em>J Nutr</em> 1989;119:529&#8211;33 [review].</li>

<li class="Ref">Keys A, ed. Coronary heart disease in seven countries. <em>Circulation</em>
1970;41(Suppl Q):I1&#8211;211.</li>

<li class="Ref">Kris-Etherton PM, Pearson TA, Wan Y, et al. High-monounsaturated fatty acid
diets lower both plasma cholesterol and triacylglycerol concentrations. <em>Am J Clin
Nutr</em> 1999;70:1009&#8211;15.</li>

<li class="Ref">Lichtenstein AH, Ausman LM, Jalbert SM, Schaefer EJ. Effects of different
forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels. <em>N Engl J
Med</em> 1999;340:1933&#8211;40.</li>

<li class="Ref">Willett WC, Stampfer MJ, Manson JE, et al. Intake of <em>trans</em> fatty
acids and risk of coronary heart disease among women. <em>Lancet</em>
1993;341:581&#8211;5.</li>

<li class="Ref">Norm&#233;n L, Dutta P, Lia &#197;, Andersson H. Soy sterol esters and
beta-sitostanol ester as inhibitors of cholesterol absorption in human small bowel. <em>Am J
Clin Nutr</em> 2000;71:908&#8211;13.</li>

<li class="Ref">Gylling H, Miettinen TA. Cholesterol reduction by different plant stanol
mixtures and with variable fat intake. <em>Metabolism</em> 1999;48:575&#8211;80.</li>

<li class="Ref">Blair SN, Capuzzi DM, Gottlieb SO, et al. Incremental reduction of serum total
cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol
ester-containing spread to statin therapy. <em>Am J Cardiol</em> 2000;86:46&#8211;52.</li>

<li class="Ref">Jones PJ, Raeini-Sarjaz M, Ntanios FY, et al. Modulation of plasma lipid
levels and cholesterol kinetics by phytosterol versus phytostanol esters. <em>J Lipid Res</em>
2000;41:697&#8211;705.</li>

<li class="Ref">Hallikainen MA, Sarkkinen ES, Uusitupa MI. Plant stanol esters affect serum
cholesterol concentrations of hypercholesterolemic men and women in a dose-dependent manner.
<em>J Nutr</em> 2000;130:767&#8211;76.</li>

<li class="Ref">Vuorio AF, Gylling H, Turtola H, et al. Stanol ester margarine alone and with
simvastatin lowers serum cholesterol in families with familial hypercholesterolemia caused by
the FH-North Karelia mutation. <em>Arterioscler Thromb Vasc Biol</em>
2000;20:500&#8211;6.</li>

<li class="Ref">Nguyen TT, Dale LC, von Bergmann K, Croghan IT. Cholesterol-lowering effect of
stanol ester in a US population of mildly hypercholesterolemic men and women: a randomized
controlled trial. <em>Mayo Clin Proc</em> 1999;74:1198&#8211;206.</li>

<li class="Ref">Moghadasian MH, Frohlich JJ. Effects of dietary phytosterols on cholesterol
metabolism and atherosclerosis: clinical and experimental evidence. <em>Am J Med</em>
1999;107:588&#8211;94 [review].</li>

<li class="Ref">Warshafsky S, Kamer RS, Sivak SL. Effect of garlic on total serum
cholesterol&#8212;a meta-analysis. <em>Ann Intern Med</em> 1993;119:599&#8211;605.</li>

<li class="Ref">McCrindle BW, Helden E, Conner WT. Garlic extract therapy in children with
hypercholesterolemia. <em>Arch Pediatr Adolesc Med</em> 1998;152:1089&#8211;94.</li>

<li class="Ref">Isaacsohn JL, Moser M, Stein EA, et al. Garlic powder and plasma lipids and
lipoproteins. <em>Arch Intern Med</em> 1998;158:1189&#8211;94.</li>

<li class="Ref">Berthold HK, Sudhop T, von Bergmann K. Effect of a garlic oil preparation on
serum lipoproteins and cholesterol metabolism. <em>JAMA</em> 1998;279:1900&#8211;2.</li>

<li class="Ref">Lawson L. Garlic oil for hypercholesterolemia&#8212;negative results. <em>
Quart Rev Natural Med Fall</em> 1998;185&#8211;6.</li>

<li class="Ref">Lawson LD. Garlic powder for hyperlipidemia&#8212;analysis of recent negative
results. <em>Quart Rev Natural Med</em> 1998;Fall:187&#8211;9.</li>

<li class="Ref">Lawson LD, Ransom DK, Hughes BG. Inhibition of whole blood
platelet-aggregation by compounds in garlic clove extracts and commercial garlic products.
<em>Thrombosis Res</em> 1992;65:141&#8211;56.</li>

<li class="Ref">Mansell P, Reckless JP. Garlic&#8212;effects on serum lipids, blood pressure,
coagulation, platelet aggregation, and vasodilatation. <em>BMJ</em> 1991;303:379&#8211;80
[editorial].</li>

<li class="Ref">Hu FB, Stampfer MJ, Manson JE, et al. Frequent nut consumption and risk of
coronary heart disease in women: prospective cohort study. <em>BMJ</em>
1998;317:1341&#8211;5.</li>

<li class="Ref">Fraser GE, Sabat&#233; J, Beeson WL, Strahan TM. A possible protective effect
of nut consumption on risk of coronary heart disease. <em>Arch Intern Med</em>
1992;152:1416&#8211;24.</li>

<li class="Ref">Abbey M, Noakes M, Belling GB, Nestel PJ. Partial replacement of saturated
fatty acids with almonds or walnuts lowers total plasma cholesterol and
low-density-lipoprotein cholesterol. <em>Am J Clin Nutr</em> 1994;59:995&#8211;9.</li>

<li class="Ref">Hu FB, Stampfer MJ. Nut consumption and risk of coronary heart disease: a
review of epidemiologic evidence. <em>Curr Atheroscler Rep</em> 1999;1:204&#8211;9.</li>

<li class="Ref">Spiller GA, Jenkins DA, Bosello O, et al. Nuts and plasma lipids: an
almond-based diet lowers LDL-C while preserving HDL-C. <em>J Am Coll Nutr</em>
1998;17:285&#8211;90.</li>

<li class="Ref">Spiller GA, Jenkins DJ, Cragen LN, et al. Effect of a diet high in
monounsaturated fat from almonds on plasma cholesterol and lipoproteins. <em>J Am Coll
Nutr</em> 1992;11:126&#8211;30.</li>

<li class="Ref">Sabat&#233; J, Fraser GE, Burke K, et al. Effects of walnuts on serum lipid
levels and blood pressure in normal men. <em>N Engl J Med</em> 1993;328:603&#8211;7.</li>

<li class="Ref">Zambon D, Campero B, Perez-Heras A, et al. Effects of walnuts on the serum
lipid profile of hypercholesterolemic subjects: the Barcelona Walnut Trial. <em>FASEB J</em>
1998;12:A506 [abstract].</li>

<li class="Ref">Zambon D, Sabate J, Munoz S, et al. Substituting walnuts for monounsaturated
fat improves the serum lipid profile of hypercholesterolemic men and women. A randomized
crossover trial. <em>Ann Intern Med</em> 2000;132:538&#8211;46.</li>

<li class="Ref">Colquhoun D, Moores D, Humphries J, Somerset S. Comparison of a high
monounsaturated fatty acid diet (enriched with macadamia nut) and a high carbohydrate diet on
blood lipids [abstract]. <em>Proceedings of the 59th European Atherosclerosis Congress</em>.
Nice, France: May 1992, 17&#8211;21.</li>

<li class="Ref">Curb JD, Wergowski G, Abbott RD, et al. High mono-unsaturated fat macadamia
nut diets: effects on serum lipids and lipoproteins. <em>FASEB J</em> 1998;12:A506
[abstract].</li>

<li class="Ref">Fraser GE. Nut consumption, lipids, and risk of a coronary event. <em>Clin
Cardiol</em> 1999;22(7 Suppl):III11&#8211;5 [review].</li>

<li class="Ref">Curb JD, Wergowske G, Dobbs JC, et al. Serum lipid effects of a
high-monounsaturated fat diet based on macadamia nuts. <em>Arch Intern Med</em>
2000;160:1154&#8211;8.</li>

<li class="Ref">Durak I, K&#246;ksal I, Ka&#231;maz M, et al. Hazelnut supplementation
enhances plasma antioxidant potential and lowers plasma cholesterol levels. <em>Clin Chim
Actia</em> 1999;284:113&#8211;5 [letter].</li>

<li class="Ref">Edwards K, Kwaw I, Matud J, Kurtz I. Effect of pistachio nuts on serum lipid
levels in patients with moderate hypercholesterolemia. <em>J Am Coll Nutr</em>
1999;18:229&#8211;32.</li>

<li class="Ref">Mirkin G. Walnuts and serum lipids. <em>N Engl J Med</em> 1993;329:358
[letter].</li>

<li class="Ref">Mann GV. Walnuts and serum lipids. <em>N Engl J Med</em> 1993;329:358
[letter].</li>

<li class="Ref">Fraser GE, Jaceldo K, Sabat&#233; J, et al. Changes in body weight with a
daily supplement of 340 calories from almonds for six months. <em>FASEB J</em> 1999;13:A539
[abstract].</li>

<li class="Ref">Fraser GE. Nut consumption, lipids, and risk of a coronary event. <em>Clin
Cardiol</em> 1999;22(7 Suppl):III11&#8211;5 [review].</li>

<li class="Ref">Durak I, K&#246;ksal I, Ka&#231;maz M, et al. Hazelnut supplementation
enhances plasma antioxidant potential and lowers plasma cholesterol levels. <em>Clin Chim
Actia</em> 1999;284:113&#8211;5 [letter].</li>

<li class="Ref">Jenkins DJA, Khan A, Jenkins AL, et al. Effect of nibbling versus gorging on
cardiovascular risk factors: serum uric acid and blood lipids. <em>Metabolism</em>
1995;44:549&#8211;55.</li>

<li class="Ref">Edelstein SL, Barrett-Connor EL, Wingard DL, Cohn BA. Increased meal frequency
associated with decreased cholesterol concentrations; Rancho Bernardo, CA, 1984&#8211;1987.
<em>Am J Clin Nutr</em> 1992;55:664&#8211;9.</li>

<li class="Ref">Reaven PD, McPhillips JB, Barrett-Connor EL, Criqui MH. Leisure time exercise
and lipid and lipoprotein levels in an older population. <em>J Am Geriatr Soc</em>
1990;38:847&#8211;54.</li>

<li class="Ref">Duncan JJ, Gordon NF, Scott CB. Women walking for health and fitness&#8212;how
much is enough? <em>JAMA</em> 1991;266:3295&#8211;9.</li>

<li class="Ref">Tran ZV, Weltman A. Differential effects of exercise on serum lipid and
lipoprotein levels seen with changes in body weight: a meta-analysis. <em>JAMA</em>
1985;254:919&#8211;24.</li>

<li class="Ref">Pekkanen J, Marti B, Nissinen A, Tuomilehto J. Reduction of premature
mortality by high physical activity: a 20-year follow-up of middle-aged Finnish men. <em>
Lancet</em> 1987;1:1473&#8211;7.</li>

<li class="Ref">Willich SN, Lewis M, Lowel H, et al. Physical exertion as a trigger of acute
myocardial infarction. <em>N Engl J Med</em> 1993;329:1684&#8211;90.</li>

<li class="Ref">Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent
risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham
Heart Study. <em>Circulation</em> 1983;67:968&#8211;77.</li>

<li class="Ref">Glueck CJ, Taylor HL, Jacobs D, et al. Plasma high-density lipoprotein
cholesterol: association with measurements of body mass: the Lipid Research Clinics Program
Prevalence Study. <em>Circulation</em> 1980;62(Suppl IV):IV62&#8211;9.</li>

<li class="Ref">Di Buono M, Hannah JS, Katzel LI, Jones PJH. Weight loss due to energy
restriction suppresses cholesterol bioshynthesis in overweight, mildly hypercholesterolemic
men. <em>J Nutr</em> 1999;129:1545&#8211;8.</li>

<li class="Ref">Wood PD, Stefanick ML, Dreon DM, et al. Changes in plasma lipids and
lipoproteins in overweight men during weight loss through dieting as compared with exercise.
<em>N Engl J Med</em> 1988;319:1173&#8211;9.</li>

<li class="Ref">Dwyer JH, Rieger-Ndakorerwa GE, Semmer NK, et al. Low-level cigarette smoking
and longitudinal change in serum cholesterol among adolescents. <em>JAMA</em>
1988;2857&#8211;62.</li>

<li class="Ref">Khosla S, Laddu A, Ehrenpreis S, Somberg JC. Cardiovascular effects of
nicotine: relation to deleterious effects of cigarette smoking. <em>Am Heart J</em>
1994;127:1669&#8211;71 [editorial/review].</li>

<li class="Ref">Nyboe J, Jensen G, Appleyard M, Schnohr P. Smoking and the risk of first acute
myocardial infarction. <em>Am Heart J</em> 1991;122:438.</li>

<li class="Ref">Kawachi I, Sparrow D, Spiro A, et al. A prospective study of anger and
coronary heart disease. <em>Circulation</em> 1996;94:2090&#8211;5.</li>

<li class="Ref">Jiang W, Babyak M, Krantz DS, et al. Mental stress-induced myocardial ischemia
and cardiac events. <em>JAMA</em> 1996;275:1651&#8211;6.</li>

<li class="Ref">Bower B. Women take un-type A behavior to heart. <em>Sci News</em>
1993;144:244.</li>

<li class="Ref">Dimsdale, JE. A perspective on type A behavior and coronary disease. <em>N
Engl J Med</em> 1988;318:110&#8211;2 [editorial/review].</li>

<li class="Ref">McCann BS, Warnick R, Knopp RH. Changes in plasma lipids and dietary intake
accompanying shifts in perceived workload and stress. <em>Psychosomatic Med</em>
1990;52:97&#8211;108.</li>

<li class="Ref">Lundberg U, Hedman M, Melin B, Frankenhaeuser M. Type A Behavior in healthy
males and females as related to physiological reactivity and blood lipids. <em>Psychosomatic
Med</em> 1989;51:113&#8211;22.</li>

<li class="Ref">Friedman M, Theresen CE, Gill JJ, et al. Alteration of type A behavior and
reduction in cardiac recurrences in postmyocardial infarction patients. <em>Am Heart J</em>
1984;108:237&#8211;48.</li>

<li class="Ref">Vuksan V, Jenkins DJ, Spadafora P, et al. Konjac-mannan (glucomannan) improves
glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A
randomized controlled metabolic trial. <em>Diabetes Care</em> 1999;22:913&#8211;9.</li>

<li class="Ref">Zhang MY, Huang CY, Wang X, et al. The effect of foods containing refined
Konjac meal on human lipid metabolism. <em>Biomed Environ Sci</em> 1990;3:99&#8211;105.</li>

<li class="Ref">Arvill A, Bodin L. Effect of short-term ingestion of konjac glucomannan on
serum cholesterol in healthy men. <em>Am J Clin Nutr</em> 1995;61:585&#8211;9.</li>

<li class="Ref">Walsh DE, Yaghoubian V, Behforooz A. Effect of glucomannan on obese patients:
a clinical study. <em>Int J Obes</em> 1984;8:289&#8211;93.</li>

<li class="Ref">Nissen S, Sharp RL, Panton L, et al. &#223;-hydroxy-&#223;-methylbutyrate
(HMB) supplementation in humans is safe and may decrease cardiovascular risk factors. <em>J
Nutr</em> 2000;130:1937&#8211;45.</li>

<li class="Ref">Frei B. Ascorbic acid protects lipids in human plasma and low-density
lipoprotein against oxidative damage. <em>Am J Clin Nutr</em> 1991;54:1113&#8211;8S.</li>

<li class="Ref">Simon JA. Vitamin C and cardiovascular disease: a review. <em>J Am Coll
Nutr</em> 1992;11:107&#8211;27.</li>

<li class="Ref">Gatto LM, Hallen GK, Brown AJ, Samman S. Ascorbic acid induces a favorable
lipoprotein profile in women. <em>J Am Coll Nutr</em> 1996;15;154&#8211;8.</li>

<li class="Ref">Balz F. Antioxidant Vitamins and Heart Disease. Presented at the 60th Annual
Biology Colloquium, Oregon State University, February 25, 1999.</li>

<li class="Ref">Galeone F, Scalabrino A, Giuntoli F, et al. The lipid-lowering effect of
pantethine in hyperlipidemic patients: a clinical investigation. <em>Curr Ther Res</em>
1983;34:383&#8211;90.</li>

<li class="Ref">Miccoli R, Marchetti P, Sampietro T, et al. Effects of pantethine on lipids
and apolipoproteins in hypercholesterolemic diabetic and non diabetic patients. <em>Curr Ther
Res</em> 1984;36:545&#8211;9.</li>

<li class="Ref">Avogaro P, Bon B, Fusello M. Effect of pantethine on lipids, lipoproteins and
apolipoproteins in man. <em>Curr Ther Res</em> 1983;33;488&#8211;93.</li>

<li class="Ref">Coronel F, Tornero F, Torrente J, et al. Treatment of hyperlipemia in diabetic
patients on dialysis with a physiological substance. <em>Am J Nephrol</em>
1991;11:32&#8211;6.</li>

<li class="Ref">Arsenio L, Bodria P, Magnati G, et al. Effectiveness of long-term treatment
with pantethine in patients with dyslipidemia. <em>Clin Ther</em> 1986;8:537&#8211;45.</li>

<li class="Ref">Prisco D, Rogasi PG, Matucci M, et al. Effect of oral treatment with
pantethine on platelet and plasma phospholipids in IIa hyperlipoproteinemia. <em>
Angiology</em> 1987;38:241&#8211;7.</li>

<li class="Ref">Gaddi A, Descovich GC, Noseda G, et al. Controlled evaluation of pantethine, a
natural hypolipidemic compound, in patients with different forms of hyperlipoproteinemia. <em>
Atherosclerosis</em> 1984;50:73&#8211;83.</li>

<li class="Ref">Da Col PG, et al. Pantethine in the treatment of hyper-cholesterolemia: a
randomized double-blind trial versus tiadenol. <em>Curr Ther Re</em>s 1984;36:314.</li>

<li class="Ref">Anderson RA, Cheng N, Bryden NA, et al. Elevated intakes of supplemental
chromium improve glucose and insulin variables in individuals with type 2 diabetes. <em>
Diabetes</em> 1997;46:1786&#8211;91.</li>

<li class="Ref">Offenbacher EG, Pi-Sunyer FX. Beneficial effect of chromium-rich yeast on
glucose tolerance and blood lipids in elderly subjects. <em>Diabetes</em>
1980;29:919&#8211;25.</li>

<li class="Ref">Press RI, Geller J, Evans GW. The effect of chromium picolinate on serum
cholesterol and apolipoprotein fractions in human subjects. <em>West J Med</em>
1990;152:41&#8211;5.</li>

<li class="Ref">Hermann J, Chung H, Arquitt A, et al. Effects of chromium or copper
supplementation on plasma lipids, plasma glucose and serum insulin in adults over age fifty.
<em>J Nutr Elderly</em> 1998;18:27&#8211;45.</li>

<li class="Ref">Riales R, Albrink MJ. Effect of chromium chloride supplementation on glucose
tolerance and serum lipids including high-density lipoprotein of adult men. <em>Am J Clin
Nutr</em> 1981;34:2670&#8211;8.</li>

<li class="Ref">Roeback JR, Hla KM, Chambless LE, Fletcher RH. Effects of chromium
supplementation on serum high-density lipoprotein cholesterol levels in men taking
beta-blockers. <em>Ann Intern Med</em> 1991;115:917&#8211;24.</li>

<li class="Ref">Uusitupa MI, Kumpulainen JT, Voutilainen E, et al. Effect of inorganic
chromium supplementation on glucose tolerance, insulin response, and serum lipids in
noninsulin-dependent diabetics. <em>Am J Clin Nutr</em> 1983;38:404&#8211;10.</li>

<li class="Ref">Uusitupa MI, Mykkanen L, Siitonen O, et al. Chromium supplementation in
impaired glucose tolerance of elderly: effects on blood glucose, plasma insulin, C-peptide and
lipid levels. <em>Br J Nutr</em> 1992;68:209&#8211;16.</li>

<li class="Ref">Boyd SG, Boone BE, Smith AR, et al. Combined dietary chromium picolinate
supplementation and an exercise program leads to a reduction of serum cholesterol and insulin
in college-aged subjects. <em>J Nutr Biochem</em> 1998;9:471&#8211;5.</li>

<li class="Ref">Wang MM, Fox EA, Stoecker BJ, et al. Serum cholesterol of adults supplemented
with brewer&#8217;s yeast or chromium chloride. <em>Nutr Res</em> 1989;9:989&#8211;98.</li>

<li class="Ref">Newman HA, Leighton RF, Lanese RR, Freedland NA. Serum chromium and
angiographically determined coronary artery disease. <em>Clin Chem</em> 1978;541&#8211;4.</li>

<li class="Ref">Brown WV. Niacin for lipid disorders. <em>Postgrad Med</em>
1995;98:185&#8211;93 [review].</li>

<li class="Ref">Guyton JR, Blazing MA, Hagar J, et al. Extended-release niacin vs gemfibrozil
for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil
Study Group. <em>Arch Intern Med</em> 2000;160:1177&#8211;84.</li>

<li class="Ref">McKenney JM, Proctor JD, Harris S, Chinchili VM. A comparison of the efficacy
and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients.
<em>JAMA</em> 1994;271:672&#8211;7.</li>

<li class="Ref">Knopp RH, Ginsberg J, Albers JJ, et al. Contrasting effects of unmodified and
time-release forms of niacin on lipoproteins in hyperlipidemic subjects: clues to mechanism of
action of niacin. <em>Metabolism</em> 1985;34:642&#8211;50.</li>

<li class="Ref">Gray DR, Morgan T, Chretien SD, Kashyap ML. Efficacy and safety of
controlled-release niacin in dyslipoproteinemic veterans. <em>Ann Intern Med</em>
1994;121:252&#8211;8.</li>

<li class="Ref">Rader JI, Calvert RJ, Hathcock JN. Hepatic toxicity of unmodified and
time-release preparations of niacin. <em>Am J Med</em> 1992;92:77&#8211;81 [review].</li>

<li class="Ref">Knopp RH. Niacin and hepatic failure. <em>Ann Intern Med</em> 1989;111:769
[letter].</li>

<li class="Ref">Goldberg A, Alagona P Jr, Capuzzi DM, et al. Multiple-dose efficacy and safety
of an extended-release form of niacin in the management of hyperlipidemia. <em>Am J
Cardiol</em> 2000;85:1100&#8211;5.</li>

<li class="Ref">Head KA. Inositol hexaniacinate: a safer alternative to niacin. <em>Alt Med
Rev</em> 1996;1:176&#8211;84 [review].</li>

<li class="Ref">Murray M. Lipid-lowering drugs vs. Inositol hexaniacinate. <em>Am J Natural
Med</em> 1995;2:9&#8211;12 [review].</li>

<li class="Ref">Dorner Von G, Fisher FW. Zur Beinflussung der Serumlipide und-lipoproteine
durch den Hexanicotinsaureester des m-Inositol. <em>Arzneimittel Forschung</em>
1961;11:110&#8211;3.</li>

<li class="Ref">Carrol KK, Kurowska EM. Soy consumption and cholesterol reduction: review of
animal and human studies. <em>J Nutr</em> 1995;125:594&#8211;7S.</li>

<li class="Ref">Crouse JR 3rd, Morgan T, Terry JG, et al. A randomized trial comparing the
effect of casein with that of soy protein containing varying amounts of isoflavones on plasma
concentrations of lipids and lipoproteins. <em>Arch Intern Med</em>
1999;159:2070&#8211;6.</li>

<li class="Ref">Nestel PJ, Yamashita T, Sasahara T, et al. Soy isoflavones improve systemic
arterial compliance but not plasma lipids in menopausal and perimenopausal women. <em>
Arterioscler Thromb Vasc Biol</em> 1997;17:3392&#8211;8.</li>

<li class="Ref">Samman S, Lyons, Wall PM, et al. The effect of supplementation with
isoflavones on plasma lipids and oxidisability of low density lipoprotein in premenopausal
women. <em>Atherosclerosis</em> 1999;147:277&#8211;83.</li>

<li class="Ref">Lees AM, Mok HY, Lees RS, et al. Plant sterols as cholesterol-lowering agents:
Clinical trials in patients with hypercholesterolemia and studies of sterol balance. <em>
Atheroscler</em> 1977;28:325&#8211;38.</li>

<li class="Ref">Pelletier X, Belbraouet S, Mirabel D, et al. A diet moderately enriched in
phytosterols lowers plasma cholesterol concentrations in normocholesterolemic humans. <em>Ann
Nutr Metab</em> 1995;39:291&#8211;5.</li>

<li class="Ref">Grundy SM, Ahrens EH Jr, Davignon J. The interaction of cholesterol absorption
and cholesterol synthesis in man. <em>J Lipid Res</em> 1969;10:304&#8211;15 [review].</li>

<li class="Ref">Hendriks HF, Weststrate JA, van Vliet T, Meijer GW. Spreads enriched with
three different levels of vegetable oil sterols and the degree of cholesterol lowering in
normocholesterolaemic and mildly hypercholesterolaemic subjects. <em>Eur J Clin Nutr</em>
1999;53:319&#8211;27.</li>

<li class="Ref">Jones PJ, Ntanios FY, Raeini-Sarjaz M, Vanstone CA. Cholesterol-lowering
efficacy of a sitostanol-containing phytosterol mixture with a prudent diet in hyperlipidemic
men. <em>Am J Clin Nutr</em> 1999;69:1144&#8211;50.</li>

<li class="Ref">Blair SN, Capuzzi DM, Gottlieb SO, et al. Incremental reduction of serum total
cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol
ester-containing spread to statin therapy. <em>Am J Cardiol</em> 2000;86:46&#8211;52.</li>

<li class="Ref">Jones PJ, Raeini-Sarjaz M, Ntanios FY, et al. Modulation of plasma lipid
levels and cholesterol kinetics by phytosterol versus phytostanol esters. <em>J Lipid Res</em>
2000;41:697&#8211;705.</li>

<li class="Ref">Hallikainen MA, Sarkkinen ES, Uusitupa MI. Plant stanol esters affect serum
cholesterol concentrations of hypercholesterolemic men and women in a dose-dependent manner.
<em>J Nutr</em> 2000;130:767&#8211;76.</li>

<li class="Ref">Vuorio AF, Gylling H, Turtola H, et al. Stanol ester margarine alone and with
simvastatin lowers serum cholesterol in families with familial hypercholesterolemia caused by
the FH-North Karelia mutation. <em>Arterioscler Thromb Vasc Biol</em>
2000;20:500&#8211;6.</li>

<li class="Ref">Nguyen TT, Dale LC, von Bergmann K, Croghan IT. Cholesterol-lowering effect of
stanol ester in a US population of mildly hypercholesterolemic men and women: a randomized
controlled trial. <em>Mayo Clin Proc</em> 1999;74:1198&#8211;206.</li>

<li class="Ref">Law M. Plant sterol and stanol margarines and health. <em>BMJ</em>
2000;320:861&#8211;4.</li>

<li class="Ref">Parker RA, Pearce BC, Clark RW, et al. Tocotrienols regulate cholesterol
production in mammalian cells by post-transcriptional suppression of
3-hydroxy-3-methylglutaryl-coenzyme A reductase. <em>J Biol Chem</em>
1993;268(15):11230&#8211;8.</li>

<li class="Ref">Pearce BC, Parker RA, Deason ME, et al. Hypocholesterolemic activity of
synthetic and natural tocotrienols. <em>J Med Chem</em> 1992;35:3595&#8211;606.</li>

<li class="Ref">Qureshi AA, Bradlow BA, Brace L, et al. Response of hypercholesterolemic
subjects to administration of tocotrienols. <em>Lipids</em> 1995;30:1171&#8211;7.</li>

<li class="Ref">Qureshi AA, Qureshi N, Wright JJ, et al. Lowering serum cholesterol in
hypercholesterolemic humans by tocotrienols (palmvitee). <em>Am J Clin Nutr</em>
1991;53:1021&#8211;6S.</li>

<li class="Ref">Wahlqvist ML, Krivokuca-Bogetic A, Lo CS, et al. Differential serum response
of tocopherols and tocotrienols during vitamin supplementation in hypercholesterolemic
individuals without change in coronary risk factors. <em>Nutr Res</em>
1992;12:S181&#8211;201.</li>

<li class="Ref">Mensink RP, van Houwelingen AC, Kromhout D, Hornstra G. A vitamin E
concentrate rich in tocotrienols had no effect on serum lipids, lipoproteins, or platelet
function in men with mildly elevated serum lipid concentrations. <em>Am J Clin Nutr</em>
1999;69:213&#8211;9.</li>

<li class="Ref">Davis GK, Mertz W. Copper. In: Mertz W, ed. <em>Trace elements in human and
animal nutrition</em>, vol. 1. 5th ed. San Diego: Academic Press, 1987, 301&#8211;64
[review].</li>

<li class="Ref">Klevay LM. Dietary copper: a powerful determinant of cholesterolemia. <em>Med
Hypotheses</em> 1987;24:111&#8211;9 [review].</li>

<li class="Ref">Hermann J, Chung H, Arquitt A, et al. Effects of chromium or copper
supplementation on plasma lipids, plasma glucose and serum insulin in adults over age fifty.
<em>J Nutr Elderly</em> 1998;18:27&#8211;45.</li>

<li class="Ref">Bell S, Goldman VM, Bistrian BR, et al. Effect of beta-glucan from oats and
yeast on serum lipids. <em>Crit Rev Food Sci Nutr</em> 1999;39:189&#8211;202 [review].</li>

<li class="Ref">Behall KM, Scholfield DJ, Hallfrisch J. Effect of beta-glucan level in oat
fiber extracts on blood lipids in men and women. <em>J Am Coll Nutr</em>
1997;16:46&#8211;51.</li>

<li class="Ref">Braaten JT, Wood PJ, Scott FW, et al. Oat beta-glucan reduces blood
cholesterol concentration in hypercholesterolemic subjects. <em>Eur J Clin Nutr</em>
1994;48:465&#8211;74.</li>

<li class="Ref">Davidson MH, Dugan LD, Burns JH, et al. The hypocholesterolemic effects of
beta-glucan in oatmeal and oat bran. A dose-controlled study. <em>JAMA</em>
1991;265:1833&#8211;9.</li>

<li class="Ref">Wood PJ. Physicochemical properties and physiological effects of the
(1----3)(1----4)-beta-D-glucan from oats. <em>Adv Exp Med Biol</em>
1990;270:119&#8211;27.</li>

<li class="Ref">Uusitupa MI, Miettinen TA, Sarkkinen ES, et al. Lathosterol and other
non-cholesterol sterols during treatment of hypercholesterolaemia with beta-glucan-rich oat
bran. <em>Eur J Clin Nutr</em> 1997;51:607&#8211;11.</li>

<li class="Ref">Lia A, Hallmans G, Sandberg AS, et al. Oat beta-glucan increases bile acid
excretion and a fiber-rich barley fraction increases cholesterol excretion in ileostomy
subjects. <em>Am J Clin Nutr</em> 1995;62:1245&#8211;51.</li>

<li class="Ref">Bell S, Goldman VM, Bistrian BR, et al. Effect of beta-glucan from oats and
yeast on serum lipids. <em>Crit Rev Food Sci Nutr</em> 1999;39:189&#8211;202 [review].</li>

<li class="Ref">Nicolosi R, Bell SJ, Bistrian BR, et al. Plasma lipid changes after
supplementation with beta-glucan fiber from yeast. <em>Am J Clin Nutr</em>
1999;70:208&#8211;12.</li>

<li class="Ref">Behall KM, Scholfield DJ, Hallfrisch J. Effect of beta-glucan level in oat
fiber extracts on blood lipids in men and women. <em>J Am Coll Nutr</em>
1997;16:46&#8211;51.</li>

<li class="Ref">Braaten JT, Wood PJ, Scott FW, et al. Oat beta-glucan reduces blood
cholesterol concentration in hypercholesterolemic subjects. <em>Eur J Clin Nutr</em>
1994;48:465&#8211;74.</li>

<li class="Ref">Uusitupa MI, Ruuskanen E, Makinen E, et al. A controlled study on the effect
of beta-glucan-rich oat bran on serum lipids in hypercholesterolemic subjects: relation to
apolipoprotein E phenotype. <em>J Am Coll Nutr</em> 1992;11:651&#8211;9.</li>

<li class="Ref">Yacowitz H, Fleischman AI, Bierenbaum ML. Effects of oral calcium upon serum
lipids in man. <em>Br Med J</em> 1965;1:1352&#8211;4.</li>

<li class="Ref">Bell L, Halstenson CE, Halstenson CJ, et al. Cholesterol-lowering effects of
calcium carbonate in patients with mild to moderate hypercholesterolemia. <em>Arch Intern
Med</em> 1992;152:2441&#8211;4.</li>

<li class="Ref">Karanja N, Morris CD, Illingworth DR, Plasma lipids and hypertension: response
to calcium supplementation. <em>Am J Clin Nutr</em> 1987;45:60&#8211;5.</li>

<li class="Ref">Denke MA, Fox MM, Schulte MC. Short-term dietary calcium fortification
increases fecal saturated fat content and reduces serum lipids in men. <em>J Nutr</em>
1993;123:1047&#8211;53.</li>

<li class="Ref">Bostick RM, Fosdick L, Grandits GA, et al. Effect of calcium supplementation
on serum cholesterol and blood pressure. <em>Arch Fam Med</em> 2000;9:31&#8211;9.</li>

<li class="Ref">Cloarec MJ, Perdriset GM, Lamberdiere FA, et al., Alpha-tocopherol: effect on
plasma lipoproteins in hypercholesterolemic patients. <em>Isr J Med Sci</em>
1987;23:869&#8211;72.</li>

<li class="Ref">Kesaniemi YA, Grundy SM. Lack of effect of tocopherol on plasma lipids and
lipoproteins in man. <em>Am J Clin Nutr</em> 1982;36:224&#8211;8.</li>

<li class="Ref">Kalbfleisch JH, Barboriak JJ, Else BA, et al. alpha-Tocopherol supplements and
high-density-lipoprotein-cholesterol levels. <em>Br J Nutr</em> 1986;55:71&#8211;7.</li>

<li class="Ref">Stampfer MJ, Willett W, Castelli WP, et al. Effect of vitamin E on lipids.
<em>Am J Clin Pathol</em> 1983;79:714&#8211;6.</li>

<li class="Ref">Belcher JD, Balla J, Balla G, et al. Vitamin E, LDL, and endothelium: brief
oral vitamin supplementation prevents oxidized LDL-mediated vascular injury in vitro. <em>
Arterioscler Thromb</em> 1993;13:1779&#8211;89.</li>

<li class="Ref">Traber MG. Does vitamin E decrease heart attack risk? summary and implications
with respect to dietary recommendations. <em>J Nutr 2001</em>;131:395S&#8211;7S.
[review].</li>

<li class="Ref">Pola P, Savi L, Grilli M, et al. Carnitine in the therapy of dyslipidemic
patients. <em>Curr Ther Res</em> 1980;27:208&#8211;16.</li>

<li class="Ref">Stefanutti C, Vivenzio A, Lucani G, et al. Effect of L-carnitine on plasma
lipoprotein fatty acids pattern in patients with primary hyperlipoproteinemia. <em>Clin
Ter</em> 1998;149:115&#8211;9.</li>

<li class="Ref">Maebashi M, Kawamura N, Sato M, et al. Lipid-lowering effect of carnitine in
patients with type-IV hyperlipoproteinaemia. <em>Lancet</em> 1978;ii:805&#8211;7.</li>

<li class="Ref">Rossi CS, Siliprandi N. Effect of carnitine on serum HDL-cholesterol: report
of two cases. <em>Johns Hopkins Med J</em> 1982;150:51&#8211;4.</li>

<li class="Ref">Pola P, Savi L, Grilli M, et al. Carnitine in the therapy of dyslipidemic
patients. <em>Curr Ther Res</em> 1980;27:208&#8211;16.</li>

<li class="Ref">Davini P, Bigalli A, Lamanna F, Boehm A. Controlled study on L-carnitine
therapeutic efficacy in post-infarction. <em>Drugs Exptl Clin Res</em>
1992;18:355&#8211;65.</li>

<li class="Ref">Davis WH, Leary WP, Reyes AJ, Olhaberry JV. Monotherapy with magnesium
increases abnormally low high density lipoprotein cholesterol: a clinical assay. <em>Curr Ther
Res</em> 1984;36:341&#8211;6.</li>

<li class="Ref">Nozue T, Kobayashi A, Uemasu F, et al. Magnesium status, serum HDL
cholesterol, and apolipoprotein A-1 levels. <em>J Pediatr Gastroenterol Nutr</em>
1995;20:316&#8211;8.</li>

<li class="Ref">Baxter GF, Sumeray MS, Walker JM. Infarct size and magnesium: insights into
LIMIT-2 and ISIS-4 from experimental studies. <em>Lancet</em> 1996;348:1424&#8211;6.</li>

<li class="Ref">Galloe A, Rasmussen HS, Jorgensen LN, et al. Influence of oral magnesium
supplementation on cardiac events among survivors of an acute myocardial infarction. <em>
BMJ</em> 1993;307:585&#8211;7.</li>

<li class="Ref">Izuka K, Murata K, Nakazawa K, et al. Effects of chondroitin sulfates on serum
lipids and hexosamines in atherosclerotic patients: With special reference to thrombus
formation time. <em>Jpn Heart J</em> 1968;9:453&#8211;60.</li>

<li class="Ref">Nakazawa K, Murata K. Comparative study of the effects of chondroitin sulfate
isomers on atherosclerotic subjects. <em>ZFA</em> 1979;34:153&#8211;9.</li>

<li class="Ref">Morrison LM, Enrick NL. Coronary heart disease: reduction of death rate by
chondroitin sulfate A. <em>Angiology</em> 1973;24:269&#8211;87.</li>

<li class="Ref">Childs MT, Bowlin JA, Ogilvie JT, et al. The contrasting effects of a dietary
soya lecithin product and corn oil on lipoprotein lipids in normolipidemic and familial
hypercholesterolemic subjects. <em>Atherosclerosis</em> 1981;38:217&#8211;28.</li>

<li class="Ref">Knuiman JT, Beynen AC, Katan MB. Lecithin intake and serum cholesterol. <em>Am
J Clin Nutr</em> 1989;49:266&#8211;8.</li>

<li class="Ref">Wilson TA, Meservey CM, Nicolosi RJ. Soy lecithin reduces plasma lipoprotein
cholesterol and early atherogenesis in hypercholesterolemic monkeys and hamsters: beyond
linoleate. <em>Atherosclerosis</em> 1998;140:147&#8211;53.</li>

<li class="Ref">Oosthuizen W, Vorster HH, Vermaak WJ, et al. Lecithin has no effect on serum
lipoprotein, plasma fibrinogen and macro molecular protein complex levels in hyperlipidaemic
men in a double-blind controlled study. <em>Eur J Clin Nutr</em> 1998;52:419&#8211;24.</li>

<li class="Ref">Koide SS. Chitin-chitosan: properties, benefits and risks. <em>Nutr Res</em>
1998;18:1091&#8211;101 [review].</li>

<li class="Ref">Maezaki Y, Tsuji K, Nakagawa Y, et al. Hypocholesterolemic effect of chitosan
in adult males. <em>Biosci Biotech Biochem</em> 1993;57:1439&#8211;44.</li>

<li class="Ref">Wuolijoki E, Hirvela T, Ylitalo P. Decrease in serum LDL cholesterol with
microcrystalline chitosan. <em>Methods Find Exp Clin Pharmacol</em> 1999;21:357&#8211;61.</li>

<li class="Ref">Abou-Hozaifa BM, Badr El-Din NK. Royal jelly, a possible agent to reduce the
nicotine-induced atherogenic lipoprotein profile. <em>Saudi Med J</em>
1995;16:337&#8211;42.</li>

<li class="Ref">Abou-Hozaifa BM, Roston AAH, El-Nokaly FA. Effects of royal jelly and honey on
serum lipids and lipoprotein cholesterol in rats fed cholesterol-enriched diet. <em>J Biomed
Sci Ther</em> 1993;9:35&#8211;44.</li>

<li class="Ref">Cho YT. Studies on royal jelly and abnormal cholesterol and triglycerides.
<em>Am Bee J</em> 1977;117:36&#8211;9.</li>

<li class="Ref">Liusov VA, Zimin IU. Experimental rational and trial of therapeutic use of bee
raising product in cardiovascular diseases. <em>Kardiologia</em> 1983;23:105&#8211;9 [in
Russian].</li>

<li class="Ref">Vittek J. Effect of royal jelly on serum lipids in experimental animals and
humans with atherosclerosis. <em>Experientia</em> 1995;51:927&#8211;35.</li>

<li class="Ref">Earnest CP, Almada AL, Mitchell TL. High-performance capillary
electrophoresis-pure creatine monohydrate reduces blood lipids in men and women. <em>Clin
Sci</em> 1996;91:113&#8211;8.</li>

<li class="Ref">Volek JS, Duncan ND, Mazzetti SA, et al. No effect of heavy resistance
training and creatine supplementation on blood lipids. <em>Int J Sport Nutr Exerc Metab</em>
2000;10:144&#8211;56.</li>

<li class="Ref">Pons P, Rodr&#237;quez M, M&#225;s R, et al. One-year efficacy and safety of
policosanol in patients with type II hypercholesterolemia. <em>Curr Ther Res</em>
1994;55:1084&#8211;92.</li>

<li class="Ref">Aneiros E, Calderson B, M&#225;s R, et al. Effect of successive dose increases
of policosanol on the lipid profile and tolerability of treatment. <em>Curr Ther Res</em>
1993;54:304&#8211;12.</li>

<li class="Ref">Castano G, Canetti M, Moreira M, et al. Efficacy and tolerability of
policosanol in elderly patients with type II hypercholesterolemia: a 12-month study. <em>Curr
Ther Res</em> 1995;56:819&#8211;23.</li>

<li class="Ref">Castano G, Tula L, Canetti M, et al. Effects of policosanol in hypertensive
patients with type II hypercholesterolemia. <em>Curr Ther Res</em> 1996;57:691&#8211;5.</li>

<li class="Ref">Menendez R, Arruzazabala L, M&#225;s R, et al. Cholesterol-lowering effect of
policosanol on rabbits with hypercholesterolaemia induced by a wheat starch-casein diet. <em>
Br J Nutr</em> 1997;77:923&#8211;32.</li>

<li class="Ref">Heinecke JW, Rosen H, Suzuki LA, Chait A. The role of sulfur-containing amino
acids in superoxide production and modification of low density lipoprotein by arterial smooth
muscle cells. <em>Biol Chem</em> 1987;262:10098&#8211;103.</li>

<li class="Ref">Ubbink JB, Hayward WJ, van der Merwe A, et al. Vitamin requirements for the
treatment of hyperhomocysteinemia in humans. <em>J Nutr</em> 1994;124:1927&#8211;33.</li>

<li class="Ref">Woodside JV, Young IS, Yarnell JW, et al. Antioxidants, but not B-group
vitamins increase the resistance of low-density lipoprotein to oxidation: a randomized,
factorial design, placebo-controlled trial. <em>Atherosclerosis</em>
1999;144:419&#8211;27.</li>

<li class="Ref">Endo A. Monacolin K, a new hypocholesterolemic agent produced by a <em>
Monascus</em> species. <em>J Antibiot</em> (Tokyo) 1979;32:852&#8211;4.</li>

<li class="Ref">Heber D, Yip I, Ashley JM, et al. Cholesterol-lowering effects of a
proprietary Chinese red-yeast-rice dietary supplement. <em>Am J Clin Nutr</em>
1999;69:231&#8211;6.</li>

<li class="Ref">Heber D, Lembertas A, Lu QY, et al. An analysis of nine proprietary Chinese
red yeast rice dietary supplements: implications of variability in chemical profile and
contents. <em>J Altern Complement Med</em> 2001;7:133&#8211;9.</li>

<li class="Ref">Olson BH, Anderson SM, Becker MP, et al. Psyllium-enriched cereals lower blood
total cholesterol and LDL cholesterol, but not HDL cholesterol, in hypercholesterolemic
adults: results of a meta-analysis. <em>J Nutr</em> 1997;127:1973&#8211;80.</li>

<li class="Ref">Anderson JW, Davidson MH, Blonde L, et al. Long-term cholesterol-lowering
effects as an adjunct to diet therapy in the treatment of hypercholesterolemia. <em>Am J Clin
Nutr</em> 2000;71:1433&#8211;8.</li>

<li class="Ref">Romero AL, Romero JE, Galaviz S, Fernandez ML. Cookies enriched with psyllium
or oat bran lower plasma LDL cholesterol in normal and hypercholesterolemic men from Northern
Mexico. <em>J Am Coll Nutr</em> 1998;17:601&#8211;8.</li>

<li class="Ref">Agarwal RC, Singh SP, Saran RK, et al. Clinical trial of gugulipid new
hypolipidemic agent of plant origin in primary hyperlipidemia. <em>Indian J Med Res</em>
1986;84:626&#8211;34.</li>

<li class="Ref">Nityanand S, Srivastava JS, Asthana OP. Clinical trials with Gugulipid&#8212;a
new hypolipidemic agent. <em>J Assoc Phys India</em> 1989; 37:323&#8211;8.</li>

<li class="Ref">Singh RB, Niaz MA, Ghosh S. Hypolipidemic and antioxidant effects of
Commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia. <em>
Cardiovasc Drugs Ther</em> 1994;8:659&#8211;64.</li>

<li class="Ref">Asgary S, Naderi GH, Sarrafzadegan N, et al. Antihypertensive and
antihyperlipidemic effects of Achillea wilhelmsii. <em>Drugs Exp Clin Res</em>
2000;26:89&#8211;93.</li>

<li class="Ref">Warshafsky S, Kamer R, Sivak S. Effect of garlic on total serum cholesterol: a
meta-analysis. <em>Ann Int Med</em> 1993;119(7)599&#8211;605.</li>

<li class="Ref">Silagy C, Neil A. Garlic as a lipid-lowering agent&#8212;a meta-analysis. <em>
J R Coll Phys</em> London 1994;28(1):39&#8211;45.</li>

<li class="Ref">Neil HA, Silagy CA, Lancaster T, et al. Garlic powder in the treatment of
moderate hyperlipidaemia: a controlled trial and a meta-analysis. <em>J R Coll Phys</em>
1996;30:329&#8211;34.</li>

<li class="Ref">McCrindle BW, Helden E, Conner WT. Garlic extract therapy in children with
hypercholesterolemia. <em>Arch Pediatr Adolesc Med</em> 1998;152:1089&#8211;94.</li>

<li class="Ref">Isaacsohn JL, Moser M, Stein EA, et al. Garlic powder and plasma lipids and
lipoproteins. <em>Arch Intern Med</em> 1998;158:1189&#8211;94.</li>

<li class="Ref">Berthold HK, Sudhop T, von Bergmann K. Effect of a garlic oil preparation on
serum lipoproteins and cholesterol metabolism. <em>JAMA</em> 1998;279:1900&#8211;2.</li>

<li class="Ref">Superko HR, Krauss RM. Garlic powder, effect on plasma lipids, postprandial
lipemia, low-density lipoprotein particle size, high-density lipoprotein subclass distribution
and lipoprotein(a). <em>J Am Coll Cardiol</em> 2000;35:321&#8211;6.</li>

<li class="Ref">Lawson L. Garlic oil for hypercholesterolemia&#8212;negative results. <em>
Quart Rev Natural Med</em> Fall 1998;185&#8211;6.</li>

<li class="Ref">Lawson LD. Garlic powder for hyperlipidemia&#8212;analysis of recent negative
results. <em>Quart Rev Natural Med</em> Fall, 1998;187&#8211;9.</li>

<li class="Ref">Berthold HK, Sudhop T, von Bergmann K. Effect of a garlic oil preparation on
serum lipoproteins and cholesterol metabolism. <em>JAMA</em> 1998;279:1900&#8211;2.</li>

<li class="Ref">Silagy C, Neil A. Garlic as a lipid-lowering agent&#8212;a meta-analysis. <em>
J R Coll Physicians London</em> 1994;28:39&#8211;45.</li>

<li class="Ref">Silagy C, Neil A. Garlic as a lipid-lowering agent&#8212;a meta-analysis. <em>
J R College Phys London</em> 1994;28:39&#8211;45.</li>

<li class="Ref">Kono S, Shinchi K, Ikeda N, et al. Green tea consumption and serum lipid
profiles: a cross-sectional study in Northern Kyushu, Japan. <em>Prev Med</em>
1992;21:526&#8211;31.</li>

<li class="Ref">Yamaguchi Y, Hayashi M, Yamazoe H, et al. Preventive effects of green tea
extract on lipid abnormalities in serum, liver and aorta of mice fed an atherogenic diet. <em>
Nip Yak Zas</em> 1991;97(6):329&#8211;37.</li>

<li class="Ref">Sagesaka-Mitane Y, Milwa M, Okada S. Platelet aggregation inhibitors in hot
water extract of green tea. <em>Chem Pharm Bull</em> 1990;38(3):790&#8211;3.</li>

<li class="Ref">Stensvold I, Tverdal A, Solvoll K, et al. Tea consumption. Relationship to
cholesterol, blood pressure, and coronary and total mortality. <em>Prev Med</em>
1992;21:546&#8211;53.</li>

<li class="Ref">Tsubono Y, Tsugane S. Green tea intake in relation to serum lipid levels in
middle-aged Japanese men and women. <em>Ann Epidemiol</em> 1997;7:280&#8211;4.</li>

<li class="Ref">Fintelmann V. Antidyspeptic and lipid-lowering effect of artichoke leaf
extract. <em>Zeitschirfit fur Allgemeinmed</em> 1996;72:1&#8211;19.</li>

<li class="Ref">Heckers H, Dittmar K, Schmahl FW, Huth K. Inefficiency of cynarin as
therapeutic regimen in familial type II hyperlipoproteinemia. <em>Atherosclerosis</em> 1977;
26:249&#8211;53.</li>

<li class="Ref">Englisch W, Beckers C, Unkauf M, et al. Efficacy of artichoke dry extract in
patients with hyperlipoproteinemia. <em>Arzneimittelforschung</em> 2000;50:260&#8211;5.</li>

<li class="Ref">Sauvaire Y, Ribes G, Baccou JC, Loubatieres-Mariani MM. Implication of steroid
saponins and sapogenins in the hypocholesterolemic effect of fenugreek. <em>Lipids</em>
1991;26:191&#8211;7.</li>

<li class="Ref">Bordia A, Verma SK, Srivastava KC. Effect of ginger (<em>Zingiber
officinale</em> Rosc) and fenugreek (<em>Trigonella foenumgraecum</em> L) on blood lipids,
blood sugar, and platelet aggregation in patients with coronary artery disease. <em>
Prostagland Leukotrienes Essential Fatty Acids</em> 1997;56:379&#8211;84.</li>

<li class="Ref">Sharma RD, Raghuram TC, Rao NS. Effect of fenugreek seeds on blood glucose and
serum lipids in type I diabetes. <em>Eur J Clin Nutr</em> 1990;44:301&#8211;6.</li>

<li class="Ref">Sharma RD, Sarkar DK, Hazra B, et al. Hypolipidaemic effect of fenugreek
seeds: a chronic study in non-insulin dependent diabetic patients. <em>Phytother Res</em>
1996;10:332&#8211;4.</li>

<li class="Ref">Sharma RD, Raghuram TC, Dayasagar Rao V. Hypolipidaemic effect of fenugreek
seeds. A clinical study. <em>Phyother Res</em> 1991;5:145&#8211;7.</li>

<li class="Ref">Prasanna M. Hypolipidemic effect of fenugreek: a clinical study. <em>Indian J
Phramcol</em> 2000;32:34&#8211;6.</li>

<li class="Ref">Sowmya P, Rajyalakshmi P. Hypocholesterolemic effect of germinated fenugreek
seeds in human subjects. <em>Plant Foods Hum Nutr</em> 1999;53:359&#8211;65.</li>

<li class="Ref">Araghiniknam M, Chung S, Nelson-White T, et al. Antioxidant activity of
dioscorea and dehydroepiandrosterone (DHEA) in older humans. <em>Life Sci</em>
1996;11:147&#8211;57.</li>

<li class="Ref">Kubo K, Nanba H. Anti-hyperliposis effect of maitake fruit body (<em>Grifola
frondosa</em>). I. <em>Biol Pharm Bull</em> 1997;20:781&#8211;5.</li>

<li class="Ref">Story JA. Alfalfa saponins and cholesterol interactions. <em>Am J Clin
Nutr</em> 1984;39:917&#8211;29. One preliminary human trial found that 120 grams per day of
heat-treated alfalfa seeds for eight weeks led to a modest reduction in cholesterol.</li>

<li class="Ref">Malinow MR, Bardana EJ, Goodnight SH. Pancytopenia during ingestion of alfalfa
seeds. <em>Lancet</em> 1981;i:615.</li>
</ol>
</div>
</body>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/High_Cholesterol.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:30:42 GMT -->
</html>

